Movember

What is Movember?

Movember FoundationMovember is the month formerly known as November, where men and women across the globe join together to raise awareness and funds for men’s health, specifically prostate cancer, testicular cancer and men’s mental health.

Men (also known as Mo Bros) sign up online at Movember.com. Starting clean-shaven on November 1st, these men donate their face for 30 days by growing and grooming the best moustache they can muster. Mo Bros effectively become walking, talking billboards for men's health raising funds and awareness along the way. Women (also known as Mo Sistas) play a key supporting role by signing up as team captains, recruiting Mo Bros, helping to raise funds, and encouraging the men in their life to take action when it comes to their health.


Movember and Prostate Cancer Canada

Prostate Cancer Canada is proud to be one of Movember’s men's health partners. Through this relationship we are advancing prostate cancer research and support services, including the TrueNTH program, for men and their families living with the disease.

Learn more:

Movember funded programs
Movember.com


 
 
 

Plaid for Dad


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More

Landmark study links tumour evolution to prostate cancer severity

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved.
More


Click here for news archive